Medical Device Reprocessing

Global medical device reprocessing will have an incremental growth in coming years. According to the WK Research, “Global Medical Device Reprocessing Professional Survey Report 2024, Forecast to 2029”, increase in prevalence of chronic disorders and surgical procedures is a key factor driving market revenue growth. The compound annual growth rate (CAGR) for the 2024-2029 period is projected to be 13.21% base on WK Research regression analysis model.

Analysts’ Viewpoint:
“The global medical device reprocessing market is fragmented, with many small and medium-sized players accounting for majority of market revenue.

Major players

are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, and introducing more effective reprocessing solutions”, said Kevin Rose, Senior analyst, in WK Research.

Market insight:
Innovation in the next generation of reusable medical devices is one of the key factor driving revenue growth of the market. Reprocessing medical devices are those that have been inspected, cleaned, tested, and sterilized in order for them to be active and safe for clinical use. Endoscopes, surgical forceps, cardiac stabilization and positioning machines, balloon inflation devices, and many more types of reprocessed medical equipment are in use. Most minimally invasive disposables and surgical tools are reprocessed. Regulatory organizations such as the Association of Medical Device Reprocessors (AMDR) have given priority to the reprocessing of medical equipment following the COVID-19 pandemic worldwide medical supply deficit. AMDR assists healthcare organizations in obtaining the Conformitè Europëenne (CE)-marked or the U.S. Food and Drug Administration (FDA)-approved remanufactured equipment. AMDR also reported that expanding reprocessing programs might assist healthcare providers to manage COVID-19-related financial constraints, more efficiently monitoring supply chains, and better planning for future hazards.
However, increased risk of hospital-acquired infections could restrain revenue growth of the medical device reprocessing market. Inadequate reprocessing of reusable medical equipment between patient usage can result in the retention of blood, tissue, and other biological material (soil). This debris may allow germs to survive the disinfection or sterilization procedure, potentially leading to Health-Care-Associated Infections (HAIs). Inadequate reprocessing can also have a negative impact on patient outcomes, such as tissue irritation from remaining reprocessing materials such as chemical disinfectants.

Competition Landscape:
In June 2022, Getinge announced the launch of its improved ED-Flow automated endoscope reprocessor, which offers its endoscope reprocessing clients a better degree of digital connectivity and data management. ED-Flow efficiently handles flexible endoscope leak testing, cleaning, and high-level disinfection with effective, trustworthy outcomes. New process indicator lights have been added, making it easier to view the state of the process from across the room. This has improved department workflow and increased efficiency. This WK Research market report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading medical device reprocessing companies that include: Stryker Corporation, Medline Industries, Johnson & Johnson Services, Inc., Innovative Health, Vanguard AG, SureTek Medical, Teleflex Incorporated, SteriPro, Medivators Inc., The 3M Company.

Segmentation of Medical Device Reprocessing Market:
According to the type, the market for medical device reprocessing is divided into: Reprocessing Support and Services and Reprocessing Medical Devices. The reprocessing medical devices segment accounted for largest revenue share. Medical equipment that may be used again for patient diagnosis and treatment is known as reusable medical devices. Medical instruments that may be reused include stethoscopes, forceps, and endoscopes. Reprocessing may involve point-of-use treatment, cleaning, packing, high-level disinfection, and sterilization, among other procedures, depending on the categorization of the device. According to the Centers for Disease Control (CDC), sterilization and disinfection are important for preventing the transmission of infectious germs to patients through medical equipment and instruments. Monitoring for sterility assurance ensures that an instrument underwent a cycle that adhered to the cycle requirements verified for the sterility assurance product. Monitoring for sterility assurance confirms that the sterilization cycle adhered to the required sterilization standards. Biological indicators, chemical indicators, Bowie-Dick tests, and reusable test packs are a few sterility assurance items.
According to the application, the market for medical device reprocessing is divided into: Cardiology, Gastroenterology, Gynecology, Orthopedics, General Surgery, and Others. The cardiology segment accounted for largest revenue share. This is attributable to increase in prevalence of cardiovascular diseases. Rapid development of less invasive treatments for diagnosis and therapy has resulted in a significant increase in medical equipment costs. Many medical devices, particularly those used in interventional cardiology and electrophysiology, are now sold as Single-Use disposable Devices (SUDs). Rising demand for reprocessed medical devices in the segment will also fuel market expansion. For instance, in May 2022, Innovative Health, LLC, which is a specialist cardiology reprocessor, announced that the business has acquired authorization to reprocess the Philips Eagle Eye Platinum digital IVUS (intravascular ultrasound) catheter. This certification effectively signals Innovative Health's entry into the cath lab arena, a move that will greatly improve the potential costing reductions of hospitals through reprocessing. The Eagle Eye, which is primarily utilized in cath labs for interventional cardiology treatments, is Innovative Health's first non-electrophysiology catheter reprocessing clearance.

Medical Device Reprocessing Market: Regional Analysis
In terms of geography, the global medical device reprocessing market has been segmented into: North America, Asia Pacific, Europe, South America, and the Middle East and Africa. The market in North America accounted for largest revenue share. This is owing to increasing financing and product introductions by big corporations, as well as strategic alliances between governments and organizations to provide better healthcare facilities and endoscopic operations. Companies are introducing and launching new products as part of their strategic initiative. For instance, in January 2022, Innovative Health, LLC, a specialist cardiology reprocessor, reported that the business has acquired authorization to reprocess Boston Scientific's INTELLAMAP ORION High-Resolution Mapping Catheter. The catheter is commonly used in atrial fibrillation catheter ablation operations. Innovative Health has developed a leading portfolio of FDA certifications to reprocess medical devices in the Electrophysiology (EP) lab, allowing EP laboratories around the country to lower procedure device costs by up to 30% without compromising patient safety or requiring treatment changes.

Frequently Asked Questions